Mr Mark Phillips
BCom (Hons), MCom, FAICD
Chair of the Board, Chair of the Remuneration and Nomination Committee, Chair of the Investment Committee, Cancer Council NSW representative on the Cancer Council Australia Board
Appointed to the Board in April 2013 and re-appointed in April 2016 and April 2019
Mr Phillips has more than 30 years’ experience in business. In a 20-year career with the Commonwealth Bank of Australia, he was instrumental in the development of a range of new business divisions. Subsequently, Mr Phillips spent more than 10 years as the Chief Executive Officer of various companies listed on the Australian Securities Exchange and as an adviser to businesses and not-for-profit organisations. He is currently Chief Executive Officer of CatholicCare Sydney, Co-chair of End Street Sleeping Collaboration Ltd, and non-executive director of Cancer Council Australia and Access Programs Australia Ltd.
Mr Nicholas Adams
Chair of the Fundraising and Marketing Committee
Elected to the Board in December 2015 and re-elected in December 2018
Mr Adams is the Chief Market Manager at Allianz Australia Insurance and has 23 years’ experience in financial services and telecommunications marketing with companies such as Telstra, Westpac, and American Express. As a marketing leader, he has expertise in customer relationship management (CRM), loyalty and digital marketing, and building data-driven marketing programs to drive both revenue and customer engagement with brands.
Mr James Butler
Member of the Remuneration and Nomination Committee, Chair of the Consumer Research Review Panel, Chair of the Relay For Life Steering Committee
Elected to the Board in December 2014 and re-elected in December 2017
Mr Butler has been an active volunteer for Cancer Council NSW for 25 years, holding roles including Chair of the Hills Relay For Life Committee, and Chair of the Western Sydney Cancer Advocacy Network. He is a trained Cancer Council NSW advocate. As a two-time cancer survivor, he understands the need to influence decision-makers around key issues that have an impact on people affected by cancer.
Mr Butler is currently Chair of Cancer Council NSW’s Consumer Research Review Panel. Mr Butler has also been a business owner for 25 years and is an active consumer representative on cancer services committees in the Western Sydney Local Health District.
Ms Christine Howard
B.Soc.Sc, Dip.App.Sc, Mid
Member of the Fundraising and Marketing Committee
Elected to the Board in December 2017
Ms Howard has 20 years of health management experience with a specific interest in understanding and responding to the health needs of rural areas. She has a background in nursing, midwifery and occupational rehabilitation before moving to executive management at the Riverina Division of General Practice in 2010. This organisation evolved into the Murrumbidgee Primary Health Network covering 124,000 square kilometres in south west NSW. As Executive Manager Planning, Commissioning and Performance, Ms Howard has ensured that primary health services funded through the network have been delivered in direct response to findings from the regional health needs assessments. The health burden of cancer in rural and regional areas continues to present as a significant challenge and one that Ms Howard is passionate about changing.
Dr John Laker AO
BEc (Hons 1) (Syd), MSc (Econ) PhD (London), HonDSc (Syd)
Chair of the Governance Committee, Chair of the Audit and Risk Committee, Cancer Council NSW representative on the Cancer Council Australia Board
Elected to the Board in December 2014 and re-elected December 2017
Dr Laker was Chairman of the Australian Prudential Regulation Authority (APRA), the regulator of the Australian financial services industry, from 2003 to 2014. An economist by training, Dr Laker had an extensive career in the Reserve Bank of Australia before his appointment to APRA, both in Australia and London, and has also worked in the Commonwealth Treasury and the International Monetary Fund (IMF).
Currently, Dr Laker is an External Expert for the IMF and has participated in a number of reviews of major banking systems. He is Chairman of ING Bank Australia, Chairman of The Banking and Finance Oath Limited and Deputy Chancellor and member of the Council of the University of Technology, Sydney. He also lectures at The University of Sydney. Dr Laker was made an Officer of the Order of Australia in 2008 and has won other professional awards for his services to the regulation of the Australian financial system.
Professor Jane Young
MBBS, MPH, PhD, FAFPHM
Chair of the Cancer Research Committee
Appointed to the Board in June 2016 and re-appointed in June 2019
Professor Young trained in medicine in the United Kingdom in 1983, undertook a Master of Public Health in 1998 and completed a PhD in applied epidemiology at The University of Sydney in 2000. She holds joint appointments with The University of Sydney, where she is Professor in Cancer Epidemiology; and Sydney Local Health District, where she is Executive Director of the Surgical Outcomes Research Centre, and Executive Director, Research for the Institute of Academic Surgery at Royal Prince Alfred Hospital.
BEc Dip Ed (UNE)
Member of the Remuneration and Nomination Committee
Appointed to the Board in October 2018
Ms Dean brings a wealth of experience and a strong community perspective. She has spent the bulk of her working life as a secondary teacher and has served on a number of Boards at a local and regional level, including as the Deputy Chair Queanbeyan Local Health Committee for 14 years.
Dr Haryana Dhillon
BSc MA(Psych) PhD
Member of the Governance Committee, Member of the Cancer Research Committee
Appointed to the Board in July 2019
Dr Haryana Dhillon (BSc MA PhD) is an Associate Professor in Psycho-Oncology at the University of Sydney. She is a Director of the Centre for Medical Psychology & Evidence-based Decision-making, School of Psychology at the University of Sydney where she co-leads the Cancer Survivorship Research Group.
Haryana has more than 25 years experience in cancer clinical research originally working with the NHMRC Clinical Trial Centre, the University of Sydney across a range of investigator-initiated cancer clinical trials. Over the past 15 years she has focused more on psycho-oncology and behavioural research.
Haryana was formerly a member of the Clinical Oncology Society of Australia Board and Chair of the Survivorship group of COSA. She is Chair of the Scientific Advisory Committee of the Psycho-Oncology Cooperative Research Group, and actively involved in leadership roles with other trials groups to promote the inclusion of patient experience and patient reported outcomes in cancer clinical trials.
Dr Jo Mitchell
BSc, Post Grad Dip Nut & Diet, MPH, DrPH, GAICD
Member of the Audit and Risk Committee, Member of the Remuneration and Nomination Committee
Appointed to the Board in November 2019
Dr Jo Mitchell has worked in preventive health for more than 30 years.
Her career has included senior public sector executive experience, most recently as policy lead for population health in NSW. This portfolio covered a range of complex and contested policy issues including drug and alcohol, HIV and sexually transmitted infections, overweight and obesity, tobacco control and viral hepatitis.
In 2018 she was awarded the Public Service Medal for her contribution to population health policy in NSW.